about
Recovery time, quality of life, and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS)Sex-specific differences in hemodialysis prevalence and practices and the male-to-female mortality rate: the Dialysis Outcomes and Practice Patterns Study (DOPPS).Bioimpedance spectroscopy for assessment of volume status in patients before and after general anaesthesia.Fluid overload in hemodialysis patients: a cross-sectional study to determine its association with cardiac biomarkers and nutritional status.Restoration of renal function does not correct impairment of uremic HDL propertiesProceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions.Novel views on new-onset diabetes after transplantation: development, prevention and treatment.Early basal insulin therapy decreases new-onset diabetes after renal transplantation.Blood volume-monitored regulation of ultrafiltration in fluid-overloaded hemodialysis patients: study protocol for a randomized controlled trial.The multifunctional role of mTOR in innate immunity: implications for transplant immunity.Hereditary amyloidosis caused by R554L fibrinogen Aα-chain mutation in a Spanish family and review of the literature.Antidiabetic therapy in post kidney transplantation diabetes mellitus.The diagnosis of posttransplantation diabetes mellitus: meeting the challenges.Sex and gender differences in chronic kidney disease: progression to end-stage renal disease and haemodialysis.Fluid status and outcome in patients with heart failure and preserved ejection fraction.Molecular regulation of the renin-angiotensin system in haemodialysis patients.Interdialytic Weight Gain: Trends, Predictors, and Associated Outcomes in the International Dialysis Outcomes and Practice Patterns Study (DOPPS).Assessment of beta-cell function and insulin secretion in subjects that underwent renal transplantation.Prophylactic CMV therapy does not improve three-yr patient and graft survival compared to preemptive therapy.Comparison of glycemic control and variability in patients with type 2 and posttransplantation diabetes mellitus.Comment on: Chakkera et al. Can new-onset diabetes after kidney transplant be prevented? Diabetes Care 2013;36:1406-1412.Sirolimus in renal transplant recipients with tuberous sclerosis complex: clinical effectiveness and implications for innate immunity.CMV late phase-induced mTOR activation is essential for efficient virus replication in polarized human macrophages.Efficacy and safety of vildagliptin in new-onset diabetes after kidney transplantation--a randomized, double-blind, placebo-controlled trial.Current evidence argues against lowering the dialysate sodium.Regional Differences in the Associations Between Prescribed Dialysate Sodium Concentration and Interdialytic Weight Gain in the Dialysis Outcomes and Practice Patterns Study.Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease.Chronic kidney disease, mineral bone disease and future risk of peripheral artery disease: Do associations rule?Feedback Control in Hemodialysis-Much Ado about Nothing?Vildagliptin and pioglitazone in patients with impaired glucose tolerance after kidney transplantation: a randomized, placebo-controlled clinical trial.Late onset Pneumocystis pneumonia in renal transplantation after long-term immunosuppression with belatacept.Dialysate sodium prescription and blood pressure in hemodialysis patients.EGFR controls bone development by negatively regulating mTOR-signaling during osteoblast differentiation.Anything Goes? High Time for Smart Blood Volume MonitorsClinical trials for treatment of NODAT: time to collaboratePredialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS)Clinical evaluation of two novel biointact PTH(1-84) assays in hemodialysis patientsMore evidence needed before lower dialysate sodium concentrations can be recommendedWhat are the Consequences of Volume Expansion in Chronic Dialysis Patients?: Defining and Measuring Fluid Overload in Hemodialysis PatientsCorrelations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients
P50
Q33801077-390FF1ED-4A46-4DB6-94E1-BBA31E79DD1FQ34414553-93C10ADE-7E7D-456D-AF06-06E391DB2D9BQ34434188-F3AE4E2E-DF25-47CE-8ECA-FD9C36500592Q34448843-8794DF7D-5BAD-496B-AE3B-C03DA64A6E8EQ35124223-910B5C9B-BB60-4925-BC7B-53694198B227Q35219625-665218C5-9B07-471D-A1DB-85B82280FA89Q35221336-7D576877-3042-4546-9D73-709E5E800DBEQ35853273-83822C1B-9349-4385-8F96-5E2141CAD2D2Q36383953-7C27CC04-DC2A-463F-8B68-A143C5D7ED9BQ37605193-CCDA183E-0CCB-4071-A587-B94BB923156CQ38095581-6ECFBCA8-8AC2-4D02-8689-ED779945FBF4Q38340187-E6CBC46B-FF4B-4EF2-9913-EF0BF02D0D3AQ38380573-06622A7C-EF5D-473F-81D5-9F8164277B6BQ38851203-9415139C-3D8E-47B4-9B7C-980A682DDB97Q39035268-34F5B76E-AB5A-4552-B832-A17DCBD4823AQ39147047-1DC94C21-FE04-4B29-BA49-6287DCA9DE81Q39170702-E11A33F6-ABC8-4DF8-87E3-55BBA0F9CA7AQ40138756-203107EE-8C91-4468-909A-08290E514140Q40956620-71ED12CB-819A-4D33-889F-2752483DAC59Q41492247-234D5047-F303-495A-90B1-CFB9313F23E9Q42970426-88CB54C7-FDC0-40FA-B3EE-58221B198BE0Q43195588-0FAFB800-63FF-427E-818B-DE99D40108D8Q43583466-2FBA8C0B-85D2-4B27-8E08-5377D3B77817Q44120755-CFF63A83-7777-4595-994F-242C21867462Q44924837-112AA108-9B61-4CF5-B492-2A94FC24439DQ47210493-B368D1F5-CF90-4C0D-BE7F-133C3F7B4698Q47558235-BD4B5311-A1E5-4433-8D53-98D34738E89BQ47846101-81BDD232-657C-4AFE-9417-4B9328F6F12AQ50091355-BCC94345-6DF3-437B-9148-CBEA9FA9DD1FQ51345165-AB61FEA3-EF42-4BE9-9993-CB58081692F3Q51826948-268F3DB6-9D3F-49A8-8F13-9B5AD66B7BB4Q53093124-C3803B63-1EA7-4FEB-A183-597D4C81F1B9Q55230047-B687C331-1C8B-4954-A4DC-F87640043C5AQ57065980-798DD10C-EB7E-4FAF-83E8-89CE78FBD9A4Q84851554-E5CBF838-13F0-4E27-B6FC-AC34AB234D0DQ84979364-D67DCB90-4498-4524-AA00-53945ADC8271Q85631846-689F2FB8-8559-4C12-A021-6D4D567D15AAQ86800270-4D4E86AF-25CF-439C-BC69-6EE9AE78441DQ86855399-C614E396-D326-4224-AE18-B609789D20CCQ88135561-125A515E-646F-4541-9DF9-79D0AF856C3C
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Manfred Hecking
@en
Manfred Hecking
@nl
type
label
Manfred Hecking
@en
Manfred Hecking
@nl
prefLabel
Manfred Hecking
@en
Manfred Hecking
@nl
P31
P496
0000-0002-8047-2395